跳至主要内容
临床试验/ACTRN12620001061921
ACTRN12620001061921招募中未知

A Registry-Based Cluster Randomised Controlled Trial to determine the clinical effectiveness and cost-effectiveness of symptom monitoring with feedback to clinicians compared with standard care in improving quality of life outcomes at 12 months for adults on haemodialysis.

HMRC Clinical Trials Centre - University of Sydney0 个研究点目标入组 2,422 人开始时间: 2020年10月16日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
2,422

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Adults aged 18 years and older with kidney failure managed with chronic haemodialysis at an Australian or New Zealand haemodialysis facility registered in ANZDATA
  • - Willing and able to comply with all study requirements
  • - Provision of consent (provided by adding name and signing in the box provided)

排除标准

  • - Paediatric centres enrolling only those under 18 years of age.

研究者

发起方
HMRC Clinical Trials Centre - University of Sydney

相似试验